Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: A systematic review and meta-analysis

European Journal of Cancer

Volumn 49, Issue 12, 2013, Pages 2665-2680

  Ku, Ja Hyeon ^a   Byun, Seok Soo ^b   Jeong, Hyeon ^c   Kwak, Cheol ^a   Kim, Hyeon Hoe ^a   Lee, Sang Eun ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Lymphovascular invasion; Meta analysis; Prognosis; Upper urinary tract; Ureter Renal pelvis; Urothelial carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; DISEASE FREE SURVIVAL; HAZARD RATIO; HUMAN; LYMPH VESSEL METASTASIS; META ANALYSIS; NEPHROURETERECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TRANSITIONAL CELL CARCINOMA;

LYMPHOVASCULAR INVASION; META-ANALYSIS; PROGNOSIS; RENAL PELVIS; UPPER URINARY TRACT; URETER; UROTHELIAL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC VESSELS; NEOPLASM INVASIVENESS; PROGNOSIS; URETERAL NEOPLASMS;

EID: 84879961723     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.04.016     Document Type: Article

References (80)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. H.G. van der Poel, N. Antonini, H. van Tinteren, and S. Horenblas Upper urinary tract cancer: location is correlated with prognosis Eur Urol 48 2005 438 444
3. M.C. Hall, S. Womack, A.I. Sagalowsky, T. Carmody, M.D. Erickstad, and C.G. Roehrborn Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients Urology 52 1998 594 601
4. S.S. Sundar, and T.S. Ganesan Role of lymphangiogenesis in cancer J Clin Oncol 25 2007 4298 4307
5. G. Gasparini, N. Weidner, and P. Bevilacqua Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma J Clin Oncol 12 1994 454 466
6. C.M. Herman, G.E. Wilcox, M.W. Kattan, P.T. Scardino, and T.M. Wheeler Lymphovascular invasion as a predictor of disease progression in prostate cancer Am J Surg Pathol 24 2000 859 863
7. R. Millikan, C. Dinney, and D. Swanson Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC J Clin Oncol 19 2001 4005 4013
8. L.P. Kunju, L. You, Y. Zhang, S. Daignault, J.E. Montie, and C.T. Lee Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens J Urol 180 2008 1928 1932
9. D.G. Altman, and R.D. Riley Primer: an evidence-based approach to prognostic markers Nat Clin Pract Oncol 2 2005 466 472
10. L. Duchateau, L. Collette, R. Sylvester, and J.P. Pignon Estimating number of events from the Kaplan-Meier curve for incorporation in a literature-based meta-analysis: what you don't see you can't get! Biometrics 56 2000 886 892
11. S. Michiels, P. Piedbois, S. Burdett, N. Syz, L. Stewart, and J.P. Pignon Meta-analysis when only the median survival times are known: a comparison with individual patient data results Int J Technol Assess Health Care 21 2005 119 125
12. T. Hirooka, C. Hamada, and I. Yoshimura A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis Methods Inf Med 48 2009 104 112
13. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
14. P.R. Williamson, C.T. Smith, J.L. Hutton, and A.G. Marson Aggregate data meta-analysis with time-to-event outcomes Stat Med 21 2002 3337 3351
15. J.F. Tierney, L.A. Stewart, D. Ghersi, S. Burdett, and M.R. Sydes Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 2007 16
16. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
17. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
18. E. Kikuchi, V. Margulis, and P.I. Karakiewicz Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma J Clin Oncol 27 2009 612 618
19. M. Roscigno, S.F. Shariat, and V. Margulis The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56 2009 512 518
20. M.I. Fernández, S.F. Shariat, and V. Margulis Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study Urology 73 2009 142 146
21. C.C. Guo, P. Tamboli, and B. Czerniak Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases Arch Pathol Lab Med 133 2009 62 66
22. M. Remzi, A. Haitel, and V. Margulis Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients BJU Int 103 2009 307 311
23. H.M. Fritsche, G. Novara, and M. Burger Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma Urol Oncol 2010 10.1016/j.urolonc.2010.07.010
24. M. Waldert, P.I. Karakiewicz, and J.D. Raman A delay in radical nephroureterectomy can lead to upstaging BJU Int 105 2010 812 817
25. L. Jankovic Velickovic, Z. Dolicanin, and T. Hattori Divergent squamous differentiation in upper urothelial carcinoma-comparative clinicopathological and molecular study Pathol Oncol Res 17 2011 535 539
26. D. Hirano, Y. Okada, and Y. Nagane Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract Urol Int 89 2012 71 77
27. M. Rink, B.D. Robinson, and D.A. Green Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma J Urol 188 2012 398 404
28. M. Vershasselt-Crinquette, P. Colin, and A. Ouzzane Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: a study using dual-color in situ hybridization and immunohistochemistry Appl Immunohistochem Mol Morphol 20 2012 363 366
29. M. Rink, B. Ehdaie, and E.K. Cha Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery Eur Urol 2012 10.1016/j.eururo.2012.02.018
30. E. Kikuchi, Y. Horiguchi, and J. Nakashima Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract J Urol 174 2005 2120 2123
31. G. Novara, V. De Marco, and F. Gottardo Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers Cancer 110 2007 1715 1722
32. K. Saito, S. Kawakami, and Y. Ohtsuka The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically BJU Int 100 2007 269 273
33. C. Bolenz, M.I. Fernández, and L. Trojan Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis BJU Int 103 2009 1040 1046
34. U. Capitanio, S.F. Shariat, and H. Isbarn Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases Eur Urol 56 2009 1 9
35. S.D. Chung, S.M. Wang, and M.K. Lai Lymphovascular invasion predicts poor outcome of urothelial carcinoma of renal pelvis after nephroureterectomy BJU Int 103 2009 1047 1051
36. V. Margulis, S.F. Shariat, and S.F. Matin Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224 1233
37. M. Ishida, S. Mikami, and E. Kikuchi Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer Carcinogenesis 31 2010 287 295
38. T. Kosaka, E. Kikuchi, and S. Mikami Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion Clin Cancer Res 16 2010 5814 5823
39. G. Novara, K. Matsumoto, and W. Kassouf Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study Eur Urol 57 2010 1064 1071
40. C. Seitz, A. Gupta, and S.F. Shariat Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study J Urol 184 2010 1895 1900
41. R. Zigeuner, S.F. Shariat, and V. Margulis Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract Eur Urol 57 2010 575 581
42. T.F. Chromecki, B. Ehdaie, and G. Novara Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy World J Urol 29 2011 473 480
43. B. Ehdaie, T.F. Chromecki, and R.K. Lee Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma J Urol 186 2011 66 72
44. Y. Ito, E. Kikuchi, and N. Tanaka Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma J Urol 185 2011 1621 1626
45. K. Matsumoto, G. Novara, and A. Gupta Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study BJU Int 108 2011 E304 E309
46. W. Otto, S.F. Shariat, and H.M. Fritsche Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients World J Urol 29 2011 487 494
47. S.F. Shariat, R.L. Favaretto, and A. Gupta Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma World J Urol 29 2011 481 486
48. T.J. Walton, G. Novara, and K. Matsumoto Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort BJU Int 108 2011 406 412
49. E.K. Cha, S.F. Shariat, and M. Kormaksson Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma Eur Urol 61 2012 818 825
50. Y. Miyazaki, T. Kosaka, and S. Mikami The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma Clin Cancer Res 18 2012 4145 4153
51. J.C. Wheat, A.Z. Weizer, and J.S. Wolf Jr. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy Urol Oncol 30 2012 252 258
52. F.A. Yafi, G. Novara, and S.F. Shariat Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy BJU Int 110 2012 E7 E13
53. P. Colin, A. Ouzzane, and G. Pignot Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study BJU Int 2012 10.1111/j.1464-410X.2012.10960.x
54. M. Roscigno, E.K. Cha, and M. Rink International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis BJU Int 2012 10.1111/j.1464-410X.2012.10930.x
55. J. Akao, H. Matsuyama, and Y. Yamamoto Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer BJU Int 102 2008 572 575
56. A. Berger, G.P. Haber, and K. Kamoi Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years J Urol 180 2008 849 854
57. K.S. Cho, N.H. Cho, and S.Y. Park Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma J Korean Med Sci 23 2008 434 438
58. D.S. Cho, S.Y. Hong, Y.K. Kim, S.I. Kim, and S.J. Kim Prognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomy Korean J Urol 52 2011 310 316
59. T.F. Chromecki, E.K. Cha, and H. Fajkovic The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy Eur Urol 61 2012 245 253
60. P. Colin, A. Ouzzane, and D.R. Yates Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival Ann Surg Oncol 2012 10.1245/s10434-012-2453-9
61. M.S. Godfrey, G.M. Badalato, G.W. Hruby, M. Razmjoo, and J.M. McKiernan Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion BJU Int 2012 10.1111/j.1464-410X.2011.10893.x
62. B. Hong, S. Park, J.H. Hong, C.S. Kim, J.Y. Ro, and H. Ahn Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract Urology 65 2005 692 696
63. S. Ishikawa, T. Abe, and N. Shinohara Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract J Urol 184 2010 883 887
64. T. Kamai, H. Shirataki, and K. Nakanishi Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer BMC Cancer 10 2010 164
65. A. Kawashima, Y. Nakai, and M. Nakayama The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study World J Urol 2011 10.1007/s00345-011-0775-z
66. D.S. Kim, Y.H. Lee, K.S. Cho, N.H. Cho, B.H. Chung, and S.J. Hong Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma Urology 75 2010 328 332
67. K. Kuroda, J. Asakuma, and A. Horiguchi Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy Urol Int 88 2012 225 231
68. S.E. Lee, S.K. Hong, and B.K. Han Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract Jpn J Clin Oncol 37 2007 49 55
69. W.C. Lin, F.C. Hu, S.D. Chung, S.C. Chueh, Y.S. Pu, and K.H. Huang The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0) J Urol 180 2008 879 884
70. B. Milojevic, M. Djokic, and S. Sipetic-Grujicic Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma Urol Oncol 2012 10.1016/j.urolonc.2012.03.004
71. K. Saito, S. Kawakami, Y. Fujii, M. Sakura, H. Masuda, and K. Kihara Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically J Urol 178 2007 2291 2296
72. T.P. Padera, A. Kadambi, and E. di Tomaso Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 2002 1883 1886
73. K. Alitalo, S. Mohla, and E. Ruoslahti Lymphangiogenesis and cancer: meeting report Cancer Res 64 2004 9225 9229
74. J. Capdet, P. Martel, and H. Charitansky Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases Eur J Surg Oncol 35 2009 1245 1249
75. K.B. Lee, K.D. Ki, and J.M. Lee The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study Ann Surg Oncol 16 2009 2882 2887
76. I. Meier, S. Merkel, T. Papadopoulos, R. Sauer, W. Hohenberger, and T.B. Brunner Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition Int J Radiat Oncol Biol Phys 70 2008 1408 1417
77. V. Margulis, Y. Lotan, F. Montorsi, and S.F. Shariat Predicting survival after radical cystectomy for bladder cancer BJU Int 102 2008 15 22
78. T.F. Chromecki, K. Bensalah, and M. Remzi Prognostic factors for upper urinary tract urothelial carcinoma Nat Rev Urol 8 2011 440 447
79. P.A. Kyzas, D. Denaxa-Kyza, and J.P. Ioannidis Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect J Natl Cancer Inst 99 2007 236 243
80. B.J. Schmitz-Dräger, P.J. Goebell, T. Ebert, and Y. Fradet P53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? Eur Urol 38 2000 691 699